Pharma & Healthcare
Global Hereditary Angioedema Drug Market Research Report 2024
- Jan 18, 24
- ID: 2584
- Pages: 83
- Figures: 190
- Views: 35
In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.
The global Hereditary Angioedema Drug market was valued at US$ 743 million in 2023 and is anticipated to reach US$ 1145.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Drug.
Report Scope
The Hereditary Angioedema Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Angioedema Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Hereditary Angioedema Drug market was valued at US$ 743 million in 2023 and is anticipated to reach US$ 1145.6 million by 2030, witnessing a CAGR of 6.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Drug.
Report Scope
The Hereditary Angioedema Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hereditary Angioedema Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hereditary Angioedema Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Hereditary Angioedema Drug Market Overview
1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Hereditary Angioedema Drug Segment by Type
1.2.1 Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Drug Segment by Application
1.3.1 Global Hereditary Angioedema Drug Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Drug Market Size Estimates and Forecasts
1.4.1 Global Hereditary Angioedema Drug Revenue 2019-2030
1.4.2 Global Hereditary Angioedema Drug Sales 2019-2030
1.4.3 Global Hereditary Angioedema Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hereditary Angioedema Drug Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hereditary Angioedema Drug Average Price by Manufacturers (2019-2024)
2.4 Global Hereditary Angioedema Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application
2.7 Hereditary Angioedema Drug Market Competitive Situation and Trends
2.7.1 Hereditary Angioedema Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
2.7.3 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hereditary Angioedema Drug Retrospective Market Scenario by Region
3.1 Global Hereditary Angioedema Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hereditary Angioedema Drug Global Hereditary Angioedema Drug Sales by Region: 2019-2030
3.2.1 Global Hereditary Angioedema Drug Sales by Region: 2019-2024
3.2.2 Global Hereditary Angioedema Drug Sales by Region: 2025-2030
3.3 Global Hereditary Angioedema Drug Global Hereditary Angioedema Drug Revenue by Region: 2019-2030
3.3.1 Global Hereditary Angioedema Drug Revenue by Region: 2019-2024
3.3.2 Global Hereditary Angioedema Drug Revenue by Region: 2025-2030
3.4 North America Hereditary Angioedema Drug Market Facts & Figures by Country
3.4.1 North America Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hereditary Angioedema Drug Sales by Country (2019-2030)
3.4.3 North America Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hereditary Angioedema Drug Market Facts & Figures by Country
3.5.1 Europe Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hereditary Angioedema Drug Sales by Country (2019-2030)
3.5.3 Europe Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hereditary Angioedema Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hereditary Angioedema Drug Market Facts & Figures by Country
3.7.1 Latin America Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hereditary Angioedema Drug Sales by Country (2019-2030)
3.7.3 Latin America Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hereditary Angioedema Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hereditary Angioedema Drug Sales by Type (2019-2030)
4.1.1 Global Hereditary Angioedema Drug Sales by Type (2019-2024)
4.1.2 Global Hereditary Angioedema Drug Sales by Type (2025-2030)
4.1.3 Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2030)
4.2 Global Hereditary Angioedema Drug Revenue by Type (2019-2030)
4.2.1 Global Hereditary Angioedema Drug Revenue by Type (2019-2024)
4.2.2 Global Hereditary Angioedema Drug Revenue by Type (2025-2030)
4.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Type (2019-2030)
4.3 Global Hereditary Angioedema Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hereditary Angioedema Drug Sales by Application (2019-2030)
5.1.1 Global Hereditary Angioedema Drug Sales by Application (2019-2024)
5.1.2 Global Hereditary Angioedema Drug Sales by Application (2025-2030)
5.1.3 Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2030)
5.2 Global Hereditary Angioedema Drug Revenue by Application (2019-2030)
5.2.1 Global Hereditary Angioedema Drug Revenue by Application (2019-2024)
5.2.2 Global Hereditary Angioedema Drug Revenue by Application (2025-2030)
5.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Application (2019-2030)
5.3 Global Hereditary Angioedema Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pharming Group NV
6.1.1 Pharming Group NV Corporation Information
6.1.2 Pharming Group NV Description and Business Overview
6.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pharming Group NV Hereditary Angioedema Drug Product Portfolio
6.1.5 Pharming Group NV Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Hereditary Angioedema Drug Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 CSL Limited
6.3.1 CSL Limited Corporation Information
6.3.2 CSL Limited Description and Business Overview
6.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Limited Hereditary Angioedema Drug Product Portfolio
6.3.5 CSL Limited Recent Developments/Updates
6.4 IBio Inc.
6.4.1 IBio Inc. Corporation Information
6.4.2 IBio Inc. Description and Business Overview
6.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IBio Inc. Hereditary Angioedema Drug Product Portfolio
6.4.5 IBio Inc. Recent Developments/Updates
6.5 BioCryst Pharmaceuticals, Inc.
6.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Ionis Pharmaceuticals, Inc.
6.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hereditary Angioedema Drug Industry Chain Analysis
7.2 Hereditary Angioedema Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hereditary Angioedema Drug Production Mode & Process
7.4 Hereditary Angioedema Drug Sales and Marketing
7.4.1 Hereditary Angioedema Drug Sales Channels
7.4.2 Hereditary Angioedema Drug Distributors
7.5 Hereditary Angioedema Drug Customers
8 Hereditary Angioedema Drug Market Dynamics
8.1 Hereditary Angioedema Drug Industry Trends
8.2 Hereditary Angioedema Drug Market Drivers
8.3 Hereditary Angioedema Drug Market Challenges
8.4 Hereditary Angioedema Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Hereditary Angioedema Drug
1.2 Hereditary Angioedema Drug Segment by Type
1.2.1 Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Drug Segment by Application
1.3.1 Global Hereditary Angioedema Drug Market Value by Application: (2024-2030)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Drug Market Size Estimates and Forecasts
1.4.1 Global Hereditary Angioedema Drug Revenue 2019-2030
1.4.2 Global Hereditary Angioedema Drug Sales 2019-2030
1.4.3 Global Hereditary Angioedema Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hereditary Angioedema Drug Market Competition by Manufacturers
2.1 Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hereditary Angioedema Drug Average Price by Manufacturers (2019-2024)
2.4 Global Hereditary Angioedema Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application
2.7 Hereditary Angioedema Drug Market Competitive Situation and Trends
2.7.1 Hereditary Angioedema Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
2.7.3 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hereditary Angioedema Drug Retrospective Market Scenario by Region
3.1 Global Hereditary Angioedema Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hereditary Angioedema Drug Global Hereditary Angioedema Drug Sales by Region: 2019-2030
3.2.1 Global Hereditary Angioedema Drug Sales by Region: 2019-2024
3.2.2 Global Hereditary Angioedema Drug Sales by Region: 2025-2030
3.3 Global Hereditary Angioedema Drug Global Hereditary Angioedema Drug Revenue by Region: 2019-2030
3.3.1 Global Hereditary Angioedema Drug Revenue by Region: 2019-2024
3.3.2 Global Hereditary Angioedema Drug Revenue by Region: 2025-2030
3.4 North America Hereditary Angioedema Drug Market Facts & Figures by Country
3.4.1 North America Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hereditary Angioedema Drug Sales by Country (2019-2030)
3.4.3 North America Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hereditary Angioedema Drug Market Facts & Figures by Country
3.5.1 Europe Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hereditary Angioedema Drug Sales by Country (2019-2030)
3.5.3 Europe Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hereditary Angioedema Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hereditary Angioedema Drug Market Facts & Figures by Country
3.7.1 Latin America Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hereditary Angioedema Drug Sales by Country (2019-2030)
3.7.3 Latin America Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Hereditary Angioedema Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hereditary Angioedema Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hereditary Angioedema Drug Sales by Type (2019-2030)
4.1.1 Global Hereditary Angioedema Drug Sales by Type (2019-2024)
4.1.2 Global Hereditary Angioedema Drug Sales by Type (2025-2030)
4.1.3 Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2030)
4.2 Global Hereditary Angioedema Drug Revenue by Type (2019-2030)
4.2.1 Global Hereditary Angioedema Drug Revenue by Type (2019-2024)
4.2.2 Global Hereditary Angioedema Drug Revenue by Type (2025-2030)
4.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Type (2019-2030)
4.3 Global Hereditary Angioedema Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hereditary Angioedema Drug Sales by Application (2019-2030)
5.1.1 Global Hereditary Angioedema Drug Sales by Application (2019-2024)
5.1.2 Global Hereditary Angioedema Drug Sales by Application (2025-2030)
5.1.3 Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2030)
5.2 Global Hereditary Angioedema Drug Revenue by Application (2019-2030)
5.2.1 Global Hereditary Angioedema Drug Revenue by Application (2019-2024)
5.2.2 Global Hereditary Angioedema Drug Revenue by Application (2025-2030)
5.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Application (2019-2030)
5.3 Global Hereditary Angioedema Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pharming Group NV
6.1.1 Pharming Group NV Corporation Information
6.1.2 Pharming Group NV Description and Business Overview
6.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pharming Group NV Hereditary Angioedema Drug Product Portfolio
6.1.5 Pharming Group NV Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Takeda Hereditary Angioedema Drug Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 CSL Limited
6.3.1 CSL Limited Corporation Information
6.3.2 CSL Limited Description and Business Overview
6.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Limited Hereditary Angioedema Drug Product Portfolio
6.3.5 CSL Limited Recent Developments/Updates
6.4 IBio Inc.
6.4.1 IBio Inc. Corporation Information
6.4.2 IBio Inc. Description and Business Overview
6.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 IBio Inc. Hereditary Angioedema Drug Product Portfolio
6.4.5 IBio Inc. Recent Developments/Updates
6.5 BioCryst Pharmaceuticals, Inc.
6.5.1 BioCryst Pharmaceuticals, Inc. Corporation Information
6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview
6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
6.6 Ionis Pharmaceuticals, Inc.
6.6.1 Ionis Pharmaceuticals, Inc. Corporation Information
6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview
6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio
6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hereditary Angioedema Drug Industry Chain Analysis
7.2 Hereditary Angioedema Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hereditary Angioedema Drug Production Mode & Process
7.4 Hereditary Angioedema Drug Sales and Marketing
7.4.1 Hereditary Angioedema Drug Sales Channels
7.4.2 Hereditary Angioedema Drug Distributors
7.5 Hereditary Angioedema Drug Customers
8 Hereditary Angioedema Drug Market Dynamics
8.1 Hereditary Angioedema Drug Industry Trends
8.2 Hereditary Angioedema Drug Market Drivers
8.3 Hereditary Angioedema Drug Market Challenges
8.4 Hereditary Angioedema Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hereditary Angioedema Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hereditary Angioedema Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hereditary Angioedema Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hereditary Angioedema Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hereditary Angioedema Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hereditary Angioedema Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hereditary Angioedema Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Hereditary Angioedema Drug Sales Market Share by Region (2019-2024)
Table 19. Global Hereditary Angioedema Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Hereditary Angioedema Drug Sales Market Share by Region (2025-2030)
Table 21. Global Hereditary Angioedema Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hereditary Angioedema Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Hereditary Angioedema Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hereditary Angioedema Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hereditary Angioedema Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hereditary Angioedema Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hereditary Angioedema Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hereditary Angioedema Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Hereditary Angioedema Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2024)
Table 53. Global Hereditary Angioedema Drug Sales Market Share by Type (2025-2030)
Table 54. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hereditary Angioedema Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Hereditary Angioedema Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Hereditary Angioedema Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Hereditary Angioedema Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2024)
Table 63. Global Hereditary Angioedema Drug Sales Market Share by Application (2025-2030)
Table 64. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hereditary Angioedema Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Hereditary Angioedema Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Pharming Group NV Corporation Information
Table 71. Pharming Group NV Description and Business Overview
Table 72. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pharming Group NV Hereditary Angioedema Drug Product
Table 74. Pharming Group NV Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Takeda Hereditary Angioedema Drug Product
Table 79. Takeda Recent Developments/Updates
Table 80. CSL Limited Corporation Information
Table 81. CSL Limited Description and Business Overview
Table 82. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. CSL Limited Hereditary Angioedema Drug Product
Table 84. CSL Limited Recent Developments/Updates
Table 85. IBio Inc. Corporation Information
Table 86. IBio Inc. Description and Business Overview
Table 87. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. IBio Inc. Hereditary Angioedema Drug Product
Table 89. IBio Inc. Recent Developments/Updates
Table 90. BioCryst Pharmaceuticals, Inc. Corporation Information
Table 91. BioCryst Pharmaceuticals, Inc. Description and Business Overview
Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 94. BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Ionis Pharmaceuticals, Inc. Corporation Information
Table 96. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 99. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Hereditary Angioedema Drug Distributors List
Table 103. Hereditary Angioedema Drug Customers List
Table 104. Hereditary Angioedema Drug Market Trends
Table 105. Hereditary Angioedema Drug Market Drivers
Table 106. Hereditary Angioedema Drug Market Challenges
Table 107. Hereditary Angioedema Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hereditary Angioedema Drug Market Share by Type in 2023 & 2030
Figure 4. C1 Esterase Inhibitor Product Picture
Figure 5. Kallikrein Inhibitor Product Picture
Figure 6. Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure 7. Global Hereditary Angioedema Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hereditary Angioedema Drug Market Share by Application in 2023 & 2030
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Hereditary Angioedema Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hereditary Angioedema Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Hereditary Angioedema Drug Sales (2019-2030) & (K Units)
Figure 15. Global Hereditary Angioedema Drug Average Price (USD/Unit) & (2019-2030)
Figure 16. Hereditary Angioedema Drug Report Years Considered
Figure 17. Hereditary Angioedema Drug Sales Share by Manufacturers in 2023
Figure 18. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Hereditary Angioedema Drug Players: Market Share by Revenue in 2023
Figure 20. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Hereditary Angioedema Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Hereditary Angioedema Drug by Type (2019-2030)
Figure 56. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Hereditary Angioedema Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Hereditary Angioedema Drug by Application (2019-2030)
Figure 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2019-2030)
Figure 60. Hereditary Angioedema Drug Value Chain
Figure 61. Hereditary Angioedema Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hereditary Angioedema Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hereditary Angioedema Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hereditary Angioedema Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hereditary Angioedema Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hereditary Angioedema Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hereditary Angioedema Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application
Table 12. Global Key Manufacturers of Hereditary Angioedema Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hereditary Angioedema Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global Hereditary Angioedema Drug Sales Market Share by Region (2019-2024)
Table 19. Global Hereditary Angioedema Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global Hereditary Angioedema Drug Sales Market Share by Region (2025-2030)
Table 21. Global Hereditary Angioedema Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hereditary Angioedema Drug Revenue Market Share by Region (2019-2024)
Table 23. Global Hereditary Angioedema Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hereditary Angioedema Drug Revenue Market Share by Region (2025-2030)
Table 25. North America Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hereditary Angioedema Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hereditary Angioedema Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hereditary Angioedema Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hereditary Angioedema Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Hereditary Angioedema Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hereditary Angioedema Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hereditary Angioedema Drug Sales (K Units) by Type (2019-2024)
Table 51. Global Hereditary Angioedema Drug Sales (K Units) by Type (2025-2030)
Table 52. Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2024)
Table 53. Global Hereditary Angioedema Drug Sales Market Share by Type (2025-2030)
Table 54. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hereditary Angioedema Drug Revenue Market Share by Type (2019-2024)
Table 57. Global Hereditary Angioedema Drug Revenue Market Share by Type (2025-2030)
Table 58. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2019-2024)
Table 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2025-2030)
Table 60. Global Hereditary Angioedema Drug Sales (K Units) by Application (2019-2024)
Table 61. Global Hereditary Angioedema Drug Sales (K Units) by Application (2025-2030)
Table 62. Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2024)
Table 63. Global Hereditary Angioedema Drug Sales Market Share by Application (2025-2030)
Table 64. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hereditary Angioedema Drug Revenue Market Share by Application (2019-2024)
Table 67. Global Hereditary Angioedema Drug Revenue Market Share by Application (2025-2030)
Table 68. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2019-2024)
Table 69. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2025-2030)
Table 70. Pharming Group NV Corporation Information
Table 71. Pharming Group NV Description and Business Overview
Table 72. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pharming Group NV Hereditary Angioedema Drug Product
Table 74. Pharming Group NV Recent Developments/Updates
Table 75. Takeda Corporation Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Takeda Hereditary Angioedema Drug Product
Table 79. Takeda Recent Developments/Updates
Table 80. CSL Limited Corporation Information
Table 81. CSL Limited Description and Business Overview
Table 82. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. CSL Limited Hereditary Angioedema Drug Product
Table 84. CSL Limited Recent Developments/Updates
Table 85. IBio Inc. Corporation Information
Table 86. IBio Inc. Description and Business Overview
Table 87. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. IBio Inc. Hereditary Angioedema Drug Product
Table 89. IBio Inc. Recent Developments/Updates
Table 90. BioCryst Pharmaceuticals, Inc. Corporation Information
Table 91. BioCryst Pharmaceuticals, Inc. Description and Business Overview
Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 94. BioCryst Pharmaceuticals, Inc. Recent Developments/Updates
Table 95. Ionis Pharmaceuticals, Inc. Corporation Information
Table 96. Ionis Pharmaceuticals, Inc. Description and Business Overview
Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product
Table 99. Ionis Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Hereditary Angioedema Drug Distributors List
Table 103. Hereditary Angioedema Drug Customers List
Table 104. Hereditary Angioedema Drug Market Trends
Table 105. Hereditary Angioedema Drug Market Drivers
Table 106. Hereditary Angioedema Drug Market Challenges
Table 107. Hereditary Angioedema Drug Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Global Hereditary Angioedema Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hereditary Angioedema Drug Market Share by Type in 2023 & 2030
Figure 4. C1 Esterase Inhibitor Product Picture
Figure 5. Kallikrein Inhibitor Product Picture
Figure 6. Selective Bradykinin B2 Receptor Antagonist Product Picture
Figure 7. Global Hereditary Angioedema Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Hereditary Angioedema Drug Market Share by Application in 2023 & 2030
Figure 9. Retail Pharmacies
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Hereditary Angioedema Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hereditary Angioedema Drug Market Size (2019-2030) & (US$ Million)
Figure 14. Global Hereditary Angioedema Drug Sales (2019-2030) & (K Units)
Figure 15. Global Hereditary Angioedema Drug Average Price (USD/Unit) & (2019-2030)
Figure 16. Hereditary Angioedema Drug Report Years Considered
Figure 17. Hereditary Angioedema Drug Sales Share by Manufacturers in 2023
Figure 18. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Hereditary Angioedema Drug Players: Market Share by Revenue in 2023
Figure 20. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 23. North America Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 27. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 28. Germany Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Region (2019-2030)
Figure 35. China Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 45. Latin America Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Hereditary Angioedema Drug Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Hereditary Angioedema Drug Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Hereditary Angioedema Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Hereditary Angioedema Drug by Type (2019-2030)
Figure 55. Global Revenue Market Share of Hereditary Angioedema Drug by Type (2019-2030)
Figure 56. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Hereditary Angioedema Drug by Application (2019-2030)
Figure 58. Global Revenue Market Share of Hereditary Angioedema Drug by Application (2019-2030)
Figure 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2019-2030)
Figure 60. Hereditary Angioedema Drug Value Chain
Figure 61. Hereditary Angioedema Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Shielded Isolator Market Research Report 2025
Jan 25, 25
Global Compressor Nebulizers Market Research Report 2025
Jan 25, 25
Global Electric Mining Truck Market Research Report 2025
Jan 25, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232